This ENO1 plasminogen receptor function, coupled with its high expression on the cell surface of tumor cells, facilitates the binding of large amounts of plasminogen on the cell surface, enabling plasmin activation, and enhancing the ability of PDAC cells to degrade extracellular matrix and, thus, benefiting the tumor invasion [127]. The gene discussed is PLG; the disease is neoplasm.